← Back to Search

Other

Intra-articular Injection of Axolotl Ambient for Osteoarthritis (Phoenix Trial)

Phase 1 & 2
Waitlist Available
Led By Robert S. Kellar, PhD
Research Sponsored by Axolotl Biologix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male and female trial participants must commit to adequate birth control (e.g., surgically sterilized, oral contraceptive, two methods of barrier birth control, or abstinence) through the final follow-up visit
Male or female at least 18 years of age and less than 80
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Phoenix Trial Summary

This trial will compare the safety and effectiveness of a new potential treatment for ankle osteoarthritis (Axolotl Ambient) to a placebo.

Who is the study for?
Adults aged 18-79 with ankle osteoarthritis, experiencing chronic pain for at least 6 months and willing to stop most pain medications can join. Women must not be pregnant and use birth control. Exclusions include major prior ankle surgery, certain medical conditions like severe bone diseases or systemic inflammatory conditions, recent treatments with similar injections or steroids in the affected joint.Check my eligibility
What is being tested?
The study tests Axolotl Ambient, an intra-articular injection for ankle osteoarthritis pain relief against a saline placebo. Participants are randomly assigned to either the treatment or placebo group without knowing which one they receive (double-blind). The trial aims to assess safety and effectiveness of the drug.See study design
What are the potential side effects?
While specific side effects aren't listed here, common ones from injections may include temporary pain at the injection site, swelling, stiffness, and possible allergic reactions. Uncommon risks might involve infection or damage to nearby structures.

Phoenix Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am using or willing to use effective birth control methods until the final follow-up.
Select...
I am between 18 and 79 years old.
Select...
I have been diagnosed with mild to moderate ankle arthritis.
Select...
My most affected joint is one ankle, and it's the only one I plan to treat.
Select...
I am using or willing to use effective birth control methods until the final follow-up.
Select...
I have had ankle pain for 6 months or more.

Phoenix Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients achieving Composite Clinical Success
Secondary outcome measures
Current Working Status
EuroQOL-5 dimension-5 level quality of life scale
Incidence of Adverse Events
+4 more

Phoenix Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Investigational GroupExperimental Treatment1 Intervention
Biological/Vaccine: Axolotl Ambient Axolotl Ambient is an allogeneic amniotic intraarticular injection therapy consisting of a growth factor and cytokine-rich fluid derived from human amnion cells. Other Names: • CA20
Group II: Control GroupPlacebo Group1 Intervention
Single dose, 2.0 mL of 0.9% normal saline, administered via intra-articular injection administered to the affected tibiotalar joint.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Axolotl BiologixLead Sponsor
Aaron J. Tabor, PhDStudy DirectorV.P. of Clinical Operations
Robert S. Kellar, PhDPrincipal InvestigatorChief Science Officer (CSO) Contact: rskellar@axobio.com Phone: 928-600-6608

Media Library

Axolotl Ambient (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05092646 — Phase 1 & 2
Osteoarthritis Research Study Groups: Control Group, Investigational Group
Osteoarthritis Clinical Trial 2023: Axolotl Ambient Highlights & Side Effects. Trial Name: NCT05092646 — Phase 1 & 2
Axolotl Ambient (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05092646 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are receiving therapy in this research project?

"That is correct. The online clinicaltrials.gov registry currently has this trial listed as open and recruiting. This particular study was posted on December 1st, 2021 and was updated on October 27th, 2022. There are 4 sites enrolling a total of 48 patients."

Answered by AI

If a patient is not yet 45 years old, are they still eligible for this clinical trial?

"By meeting the age requirements of 18 years or older, and 80 years or younger, potential patients can adhere to the age bracket set by the inclusion criteria."

Answered by AI

If I am eligible, can I sign up for this research opportunity?

"Those afflicted with arthrosis and aged between 18 and 80 may be eligible for this clinical trial, of which the researchers are looking for a total of 48 individuals."

Answered by AI

Can people with the relevant medical condition still enroll in this trial?

"Yes. The trial, which was posted on December first 2021 and updated on October 27th 2022, is currently looking for 48 patients from 4 different medical centres."

Answered by AI
~4 spots leftby Apr 2025